Return to Special Authority drug list
Generic name |
methylphenidate extended-release |
---|---|
Strength & form |
18 mg/27 mg/36 mg/54 mg extended-release tablet |
Special Authority criteria |
Approval period |
---|---|
For the treatment of attention deficit hyperactivity disorder (ADHD) in patients 6 years of age and older who require 12 hours of continuous coverage for hyperactivity, impulsivity, or inattention that interferes with functioning AND have been previously tried on one of the following with unsatisfactory results1 or intolerance:
OR
|
Indefinite |
1"Unsatisfactory results" is defined as no demonstrated effectiveness for symptoms of ADHD or functional impairment secondary to ADHD after a minimum 1 week trial of an adequate dose of immediate-release or sustained-release medication. Specific details of drug, dose and duration tried, and unsatisfactory response are required, as applicable